← Oncology Approval Tracker

FDA DECISION ·

Fludarabine Phosphate Injection

fludarabine phosphate · Sandoz

FDA approvalNew or expanded indicationChronic lymphocytic leukemia
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with B-cell chronic lymphocytic leukemia as part of combination therapy, or after lack of response or progression during at least one alkylator-containing regimen.

LAMPGEN ANALYSIS

Why it matters

The Project Renewal update added a combination indication and aligned the older label with the evidence for use with cyclophosphamide and rituximab.

What research teams should watch

Review order sets against the updated combination schedule and carry forward infection, marrow and transfusion precautions.

PRIMARY RECORDS

Sources